SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-065940
Filing Date
2017-12-29
Accepted
2017-12-29 17:26:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv482321_sc13g.htm SC 13G 52144
  Complete submission text file 0001144204-17-065940.txt   53696
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-56243 | Film No.: 171282746
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address UNIT 2706 MICHELANGELO TOWERS 8 MAUDE STREET SANDTON T3 2416
Business Address
Shabtai Gilad (Filed by) CIK: 0001726027 (see all company filings)

Type: SC 13G